Cyclophosphamide trials for Melanoma Stage IV

All Cyclophosphamide trials · All Melanoma Stage IV trials

Phase breakdown

Recruiting trials studying Cyclophosphamide for Melanoma Stage IV

• Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
  NCT05296564 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
  NCT06771544 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
  NCT06204991 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study Cyclophosphamide for Melanoma Stage IV?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.